- Published on:
Havana, Jul 30 (Prensa Latina) The first 44 adolescents in Camagüey province, who were included in the 'Ismaelillo' clinical trial with Cuba's Abdala vaccine, have already received their second dose, the Genetic Engineering and Biotechnology Center (CIGB) reported on Friday.